Science 37

Science 37, AOBiome complete virtual clinical trial

Wednesday, October 25, 2017

Science 37, a trailblazing company focused on “site-less” clinical trials, announced the completion of a phase IIb study for AOBiome, a clinical-stage life sciences company, in which it screened over 8,000 people with mild-to-moderate acne and enrolled 372 participants to take part in this research study all from the comfort of their own homes. This is the first time that a phase IIb interventional randomized placebo controlled trial of this kind has been successfully run one hundred percent virtually.

[Read More]

Sanofi bets on virtual clinical trials

Monday, March 13, 2017

The clinical research industry is facing a crisis. Nearly 80% of trials do not meet enrollment timelines, and these delays can amount to $8 million in lost revenue per day, according to one estimate by Cutting Edge Information. But now the industry is betting on a new trend: virtual clinical research.

[Read More]

Science 37 to expand clinical trial access to anyone, anywhere, anytime

Monday, October 24, 2016

Science 37, a technology-enabled clinical research company, has completed a $31 million Series B financing. Science 37 is reimagining clinical research by bringing clinical trials to people’s homes, which unlocks access to those beyond a geographical barrier. The investment will help the company grow operations, further develop its novel technology platform and continue to expand into new therapeutic areas.

[Read More]

Three Questions: Noah Craft, Science 37

Monday, December 7, 2015

CWWeekly presents this feature as a way to put the spotlight on issues faced by executives in the clinical trial space. Staff Writer Ron Rosenberg spoke to Noah Craft, M.D., Ph.D., co-founder of Los Angeles-based Science 37, which seeks to transform biomedical discovery and reduce clinical trial costs using a mobile research platform to simplify the process of participating in clinical studies.

[Read More]

Science 37 to launch clinical trial research operating model

Friday, October 23, 2015

Science 37, a Los Angeles-based technology-enabled clinical research company, has completed a $6.5 million Series A financing co-led by Lux Capital and dRx Capital. The investment will accelerate Science 37’s development and rollout of its new operating model, which is designed to solve some of the greatest inefficiencies in conducting clinical trials.

[Read More]